Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 17 of 19
Evaluation of a Yoga Intervention for Post-Traumatic Stress Disorder
NCT00962403
Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy
NCT00988962
Implementing a Comprehensive Handoff Program to Improve Patient Safety
NCT01130987
Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease
NCT00939237
A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass
NCT00955266
Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement
NCT01376011
Ear Electro-stimulation for Chronic Pelvic Pain
NCT01345331
Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects
NCT00898222
Effects of Daytime Eszopiclone Administration in Shift Workers
NCT00900159
Discharge ALERT: Quality Improvement Initiative
NCT00853463
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
NCT01564069
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
NCT01988129
Patient Rheumatoid Arthritis Social Support Study
NCT01525654
Goal-directed Fluid Resuscitation in Acute Pancreatitis
NCT00853515
BK Treatment Study
NCT01034176
Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
NCT01406015
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
NCT01502644
Diabetes Prevention in Women With a Recent History of Gestational Diabetes (Focus Groups)
NCT01102530
The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome
NCT01102270
Flavanol-Rich Cocoa and Cerebral Blood Flow
NCT00825695
Treatment of Bronchial Asthma With Borage and Echium Seed Oils
NCT00806442
Living Well With Rheumatoid Arthritis
NCT00869349
Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab
NCT00842699
Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients
NCT01591382
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124
An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)
NCT01338636
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
NCT00729430
Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease
NCT00686855
Evaluation of a Yoga Program in Schools
NCT01348893
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy
NCT00709397
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
NCT00706446
Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts
NCT00657462
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
NCT00670202
Modulation of Cerebral Blood Flow Using Iron Chelators
NCT01365104
Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy
NCT00818766
Effect of Amount and Type of Dietary Carbohydrates on Risk for Cardiovascular Heart Disease and Diabetes
NCT00608049
Cocoa, Polyphenols, and the Kidney in Healthy Subjects and in Subjects With Hypertension and Diabetes Mellitus
NCT00639665
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
NCT00723073
How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment
NCT00595361
Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary Disease
NCT00595114
Evaluating Ways to Improve Medication Use Among People With Osteoporosis
NCT00567294
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
NCT00571298
A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
NCT00566774
A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
NCT00719914
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
NCT00723801
Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome
NCT00527566
Falls - Tailoring Interventions for Patient Safety
NCT00675935
3 Screen Electronic Alert
NCT00550082
Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients
NCT00676130
A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients
NCT00675987
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.